TY - JOUR
T1 - Estimating the ratio of multivariate recurrent event rates with application to a blood transfusion study
AU - Ning, Jing
AU - Rahbar, Mohammad H.
AU - Choi, Sangbum
AU - Piao, Jin
AU - Hong, Chuan
AU - Del Junco, Deborah J.
AU - Rahbar, Elaheh
AU - Fox, Erin E.
AU - Holcomb, John B.
AU - Wang, Mei Cheng
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research is funded by the National Heart, Lung and Blood Institute (NHLBI; R21 HL109479), awarded to The University of Texas Health Science Center at Houston (UTHSC-H). We also acknowledge that the data used in this paper are from the PROMMTT study, which was funded by the U.S. Army Medical Research and Materiel Command subcontract W81XWH-08-C-0712. Infrastructure for the PROMMTT Data Coordinating Center was supported by CTSA funds from NIH/NCATS grant UL1 TR000371. The views and opinions expressed in this manuscript are those of the authors and do not reflect the official policy or position of the NHLBI, NIH, NCATS, the Army Medical Department, Department of the Army, the Department of Defense, or the United States Government.
Publisher Copyright:
© The Author(s) 2017.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - In comparative effectiveness studies of multicomponent, sequential interventions like blood product transfusion (plasma, platelets, red blood cells) for trauma and critical care patients, the timing and dynamics of treatment relative to the fragility of a patient's condition is often overlooked and underappreciated. While many hospitals have established massive transfusion protocols to ensure that physiologically optimal combinations of blood products are rapidly available, the period of time required to achieve a specified massive transfusion standard (e.g. a 1:1 or 1:2 ratio of plasma or platelets:red blood cells) has been ignored. To account for the time-varying characteristics of transfusions, we use semiparametric rate models for multivariate recurrent events to estimate blood product ratios. We use latent variables to account for multiple sources of informative censoring (early surgical or endovascular hemorrhage control procedures or death). The major advantage is that the distributions of latent variables and the dependence structure between the multivariate recurrent events and informative censoring need not be specified. Thus, our approach is robust to complex model assumptions. We establish asymptotic properties and evaluate finite sample performance through simulations, and apply the method to data from the PRospective Observational Multicenter Major Trauma Transfusion study.
AB - In comparative effectiveness studies of multicomponent, sequential interventions like blood product transfusion (plasma, platelets, red blood cells) for trauma and critical care patients, the timing and dynamics of treatment relative to the fragility of a patient's condition is often overlooked and underappreciated. While many hospitals have established massive transfusion protocols to ensure that physiologically optimal combinations of blood products are rapidly available, the period of time required to achieve a specified massive transfusion standard (e.g. a 1:1 or 1:2 ratio of plasma or platelets:red blood cells) has been ignored. To account for the time-varying characteristics of transfusions, we use semiparametric rate models for multivariate recurrent events to estimate blood product ratios. We use latent variables to account for multiple sources of informative censoring (early surgical or endovascular hemorrhage control procedures or death). The major advantage is that the distributions of latent variables and the dependence structure between the multivariate recurrent events and informative censoring need not be specified. Thus, our approach is robust to complex model assumptions. We establish asymptotic properties and evaluate finite sample performance through simulations, and apply the method to data from the PRospective Observational Multicenter Major Trauma Transfusion study.
KW - Informative censoring
KW - multivariate recurrent event
KW - rate ratio
KW - transfusion medicine
UR - http://www.scopus.com/inward/record.url?scp=85027676705&partnerID=8YFLogxK
U2 - 10.1177/0962280215593974
DO - 10.1177/0962280215593974
M3 - Article
C2 - 26160825
AN - SCOPUS:85027676705
SN - 0962-2802
VL - 26
SP - 1969
EP - 1981
JO - Statistical Methods in Medical Research
JF - Statistical Methods in Medical Research
IS - 4
ER -